United Therapeutics Advances to Second Cohort in Phase I Trial of PSTI’s PLX-PAD Cells – Video

Posted: September 14, 2014 at 8:41 pm




United Therapeutics Advances to Second Cohort in Phase I Trial of PSTI #39;s PLX-PAD Cells
HAIFA, Israel, Sept. 8, 2014 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (PSTI) (TASE:PLTR), a leading developer of placenta-based cell therapy products, announced today that its licensee,...

By: CorporateProfile

Read the original here:
United Therapeutics Advances to Second Cohort in Phase I Trial of PSTI's PLX-PAD Cells - Video


Comments are closed.

Archives